Mark Breidenbach Profile - Oppenheimer Analyst
585 Followers
Mark Breidenbach's Stock Coverage
| SYRSSyros Pharmaceuticals | Jun 23, 2023 | BUY | Assigned | ― | 26Ratings | -25.37% | ||
| CGENCompugen | Jun 23, 2023 | BUY | Assigned | ― | 26Ratings | +9.95% | ||
| BLRXBioline RX Ltd Sponsored ADR | May 25, 2023 | BUY | Reiterated | $4.00 | 37Ratings | -16.95% | ||
| ARVNArvinas Holding Company | May 08, 2023 | BUY | Reiterated | $95.00 | 17Ratings | -6.99% | ||
| SYBXSynlogic | Mar 23, 2023 | BUY | Reiterated | $120.00 | 23Ratings | -57.52% | ||
| CUECue Biopharma | Mar 22, 2023 | BUY | Reiterated | $10.00 | 16Ratings | -26.15% | ||
| NRIXNurix Therapeutics | Mar 20, 2023 | BUY | Reiterated | ― | 2Ratings | +35.80% | ||
| CRBUCaribou Biosciences | Mar 10, 2023 | BUY | Reiterated | $32.00 | 5Ratings | -28.40% | ||
| IMRXImmuneering | Mar 06, 2023 | BUY | Reiterated | $25.00 | 2Ratings | +36.65% | ||
| MBIOMustang Bio | Mar 03, 2023 | HOLD | Assigned | ― | 29Ratings | -38.86% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Mark Breidenbach activity FAQ
What is the performance of Mark Breidenbach's recommendations?
The percentage of profitable recommendations made by Mark Breidenbach is 34.34%, and the average return per transaction is 2.50%.
What stocks does Mark Breidenbach cover?
Mark Breidenbach mostly covers Compugen, Syros Pharmaceuticals, Bioline RX Ltd Sponsored ADR stocks.
What was Mark Breidenbach's most profitable rating?
Mark Breidenbach’s most profitable rating was a buy on FTSV stock on Aug 14, 2019. The return on the trade was 800.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here